Anna Capasso

Effects of vitamin E and C on placental oxidative stress: an in vitro evidence for the potential therapeutic or prophylactic treatment of preeclampsia.

Beta-endorphin fragments (DT gamma E and DE gamma E) reduce opiate withdrawal in guinea pig ileum.

Dexamethasone reduces morphine-induced Straub reaction in mice.

Pharmacological studies and synthesis of morpholino alkyl derivatives.

Vas deferens response to selective opioid receptor agonists in adult mice is impaired following postnatal repeated mild stress.

Alpha2-adrenoceptor antagonist SL 84.0418 reduces the expression of neocortical spike-and-wave spindling episodes in DBA/2J mice.

Petrosaspongiolide M reduces morphine withdrawal in vitro.

The effect of papaverine on acute opiate withdrawal in guinea pig ileum.

Alkaloids from Brugmansia arborea (L.) Lagerhein reduce morphine withdrawal in vitro.

Food and red wine do not exert acute effects on vascular reactivity.

Neurophysiological studies of Heteropteris glabra Hok. & Arn. (Malpighiaceae) in DBA/2J mice.

Affinity of Iresine herbstii and Brugmansia arborea extracts on different cerebral receptors.

In vitro antiproliferative effect of six Salvia species on human tumor cell lines.

Binding studies for serotoninergic, dopaminergic and noradrenergic receptors of Valeriana adscendens Trel. extracts.

Administration of antisense oligonucleotide against pro-opiomelanocortin prevents enduring hormonal alterations induced by neonatal handling in male mice.

Differential effects of three species of Hypericum in an open field test.

Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists.

Evaluation of antioxidative properties of Allium species growing wild in Italy.

The effect of flavonol glycosides on opiate withdrawal.

Bioactivity of new mu and delta opioid peptides.

In vitro binding receptors study by Valeriana adscendens, Iresine herbstii and Brugmansia arborea extracts.

Glucocorticoids involvement in the control of CNS excitability.

The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians.

Functional interference of dexamethasone on some morphine effects: hypothesis for the steroid-opioid interaction.

Methisergide selective inhibition of opioid acute physical dependence in isolated tissues.

The involvement of prostaglandins and nitric oxide in the development of brain excitability: a relationship study.

Pharmacological profile of SSRIs and SNRIs in the treatment of eating disorders.

Recent clinical aspects of eating disorders.

Beta-endorphin fragments DTgammaE and DEgammaE reduced morphine inhibition of electrically-induced contractions and opiate withdrawal.

The effects of the 3,4-methylenedioxymethamphetamine (Ecstasy) in some cerebral areas: role of the oxidative stress.

Functional interaction between purinergic system and opioid withdrawal: in vitro evidence.

Neurobiology of pain in children: an overview.

AMP-activated protein kinase: a physiological off switch for murine gastric acid secretion.

Migraine: an overview.

Saponins and polyphenols from Fadogia ancylantha (makoni tea).

Molecules Acting on CB1 Receptor and their Effects on Morphine Withdrawal In Vitro.

Detecting the surface localization and cytoplasmic cleavage of membrane-bound proteins.

Rapamycin-induced phosphaturia.

Genomic and proteomic approaches to renal cell carcinoma.

Enhanced eryptosis of erythrocytes from gene-targeted mice lacking annexin A7.

Sexual dimorphic evolution of metabolic programming in non-genetic non-alimentary mild metabolic syndrome model in mice depends on feed-back mechanisms integrity for pro-opiomelanocortin-derived endogenous substances.

Potential therapeutic effects of vitamin e and C on placental oxidative stress induced by nicotine: an in vitro evidence.

Post-natal stress-induced endocrine and metabolic alterations in mice at adulthood involve different pro-opiomelanocortin-derived peptides.

Synergistic antitumor activity of sorafenib in combination with epidermal growth factor receptor inhibitors in colorectal and lung cancer cells.

Recent clinical aspects of hyperprolactinemia induced by antipsychotics.

Sesquiterpene coumarins from Ferula gumosa.

Xolair in asthma therapy: an overview.

Neuroinflammation and ageing: current theories and an overview of the data.

Neuroinflamm-aging and neurodegenerative diseases: an overview.

Interconverting flavanone glucosides and other phenolic compounds in Lippia salviaefolia Cham. ethanol extracts.

Duloxetine in the treatment of depression: an overview.

Triterpenoid constituents from the roots of Paeonia rockii ssp. rockii.

Iridoid, phenylethanoid and flavonoid glycosides from Sideritis trojana.

Cycloartane glycosides from Astragalus stereocalyx Bornm.

Xanthohumol induces apoptosis in human malignant glioblastoma cells by increasing reactive oxygen species and activating MAPK pathways.

Efficacy and tolerability of vinorelbine in the cancer therapy.

Night eating syndrome: an overview.

Antiproliferative steroidal glycosides from Digitalis ciliata.

Vinorelbine in cancer therapy.

Role of lipid rafts/caveolae in the anticancer effect of endocannabinoids.

Migraine and genetic polymorphisms: an overview.

Enhanced brain performance in mice following postnatal stress.

Antioxidant action and therapeutic efficacy of Allium sativum L.

Targeted approach to metastatic colorectal cancer: what comes beyond epidermal growth factor receptor antibodies and bevacizumab?

Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells.

Cyclohexa-2,5-diene-1,4-dione-based antiproliferative agents: design, synthesis, and cytotoxic evaluation.

Steroidal glycosides with antiproliferative activities from Digitalis trojana.

Agomelatine efficacy in the night eating syndrome.

Antipsychotic drugs opposite to metabolic risk: neurotransmitters, neurohormonal and pharmacogenetic mechanisms underlying with weight gain and metabolic syndrome.

Increased TGF-α as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.

Cycloartane glycosides from Astragalus plumosus var. krugianus and evaluation of their antioxidant potential.

Primary and acquired resistance of colorectal cancer cells to anti-EGFR antibodies converge on MEK/ERK pathway activation and can be overcome by combined MEK/EGFR inhibition.

Crystallographic study and biological evaluation of 1,4-dimethyl-N-alkylcarbazoles.

(6-bromo-1,4-dimethyl-9H-carbazol-3-yl-methylene)-hydrazine (carbhydraz) acts as a GPER agonist in breast cancer cells.

The changing landscape of phase I trials in oncology.

Effect of Docosahexaenoic Acid on Cell Cycle Pathways in Breast Cell Lines With Different Transformation Degree.

The changing landscape of phase I trials in oncology.

Cannabinoids for the Treatment of Schizophrenia: An Overview.

The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance.

Antitumor activity of the aurora a selective kinase inhibitor, alisertib, against preclinical models of colorectal cancer.